PDT Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,726
Closed -$355K 741
2022
Q4
$355K Sell
1,726
-174
-9% -$44K 0.06% 452
2022
Q3
$528K Buy
+1,900
New +$483K 0.08% 426
2022
Q2
Sell
-3,591
Closed -$745K 1198
2022
Q1
$745K Buy
+3,591
New +$592K 0.06% 470
2021
Q1
Sell
-10,233
Closed -$1.06M 904
2020
Q4
$1.06M Buy
+10,233
New +$886K 0.07% 314

Other funds holding SWAV

PDT Partners's SWAV Position: Q1 2023 in Review

PDT Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 1,726 shares — an estimated $355K sold.

PDT Partners first reported a position in SWAV in Q4 2020 and held it in 4 quarters. The position peaked at $1.06M in Q4 2020. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • PDT Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 1,726 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $355K.
  • PDT Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • PDT Partners's Shockwave Medical, Inc. Common Stock position peaked at $1.06M in Q4 2020.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.